SynthesisFrontiers in medicine2025
Clinical pharmacist-led interventions and their impact on outcomes in patients with bipolar I disorder: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of pharmaceutical care interventions amid pharmacist role transformation in China: a meta-analysis.Frontiers in public health · 2026Pooled it
- Impact of Pharmacist-Led Interventions on Patient Outcomes in Gulf Cooperation Council Countries: A Systematic Review and Meta-Analysis.Pharmacy (Basel, Switzerland) · 2026Review
- Impact of Traditional Korean Medicine on Reducing Polypharmacy and Potentially Inappropriate Medications in Elderly Stroke Patients: A Retrospective Cohort Study.Journal of multidisciplinary healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pharmacist-led interventions have increasingly been recognized as effective strategies for improving outcomes in psychiatric care, yet their role in patients with bipolar I disorder (BD-I) remains underexplored. This systematic review and meta-analysis synthesized existing evidence on the impact of clinical pharmacist-led interventions (defined as medication education, medication review, adherence support, relapse monitoring, and collaborative care with psychiatrists) on medication adherence, relapse prevention, hospitalization, and quality of life among individuals with BD-I. Objectives: To evaluate the effectiveness of pharmacist-led interventions, either alone or in collaboration with psychiatrists, on key clinical and humanistic outcomes in adults diagnosed with BD-I. Methods: Electronic databases (PubMed/MEDLINE, Embase, PsycINFO, Scopus, Web of Science, and the Cochrane Library) were searched from January 2000 to August 2025 for randomized controlled trials and non-randomized quasi-experimental designs (prospective cohort studies and pre-post intervention studies) assessing pharmacist-led interventions in BD-I. Studies were screened and appraised independently in accordance with PRISMA 2020 guidelines, using the Cochrane RoB 2 tool for randomized controlled trials and the Newcastle-Ottawa Scale for non-randomized studies. Meta-analyses were performed using Review Manager (RevMan 5.4). Primary outcomes were medication adherence, relapse, hospitalization, and health-related quality of life (QoL). Secondary outcomes included any additional clinical or humanistic measures reported by the included studies. Effect sizes were expressed as odds ratios (ORs) for dichotomous outcomes and as mean differences (MDs) or standardized mean differences (SMDs) for continuous outcomes, each reported with 95% confidence intervals (CIs). Results: Five studies met the eligibility criteria, and four contributed quantitative data. Pharmacist-led interventions significantly improved medication adherence compared with usual care (MD = 1.47 [95% CI: 1.35-1.59], Conclusion: Clinical pharmacist-led interventions significantly enhance medication adherence and quality of life and may reduce relapse risk among patients with BD-I. However, given the limited number of studies and small pooled sample sizes, the overall evidence remains preliminary, and the findings should be interpreted cautiously rather than as definitive conclusions. Further large-scale, multicenter studies are warranted to confirm these benefits and assess cost-effectiveness. Systematic review registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD420251123737 04/10/2025].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.